"To be or not to be in a good Shape": Diagnostic and clinical value of nuclear shape irregularities in thyroid and breast cancer

Gianni Bussolati, Francesca Maletta, Sofia Asioli, Laura Annaratone, Anna Sapino, Caterina Marchiò

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Variation in both nuclear shape and size ("pleomorphism"), coupled with changes in chromatin amount and distribution, remains the basic criteria for microscopy in a cytologic diagnosis of cancer. The biological determinants of nuclear shape irregularities are not clarified, so, rather than on the genesis of nuclear irregularities, we here focus our attention on a descriptive analysis of nuclear pleomorphism. We keep in mind that evaluation of nuclear shape as currently practiced in routine preparations is improper because it is indirectly based on the distribution of DNA as revealed by the affinity for basic dyes. Therefore, over the last years we have been using as criteria morphological features of nuclei of thyroid and breast carcinomas as determined by immunofluorescence, in situ hybridization, and 3D reconstruction. We have translated this approach to routine diagnostic pathology on tissue sections by employing immunoperoxidase staining for emerin. Direct detection of nuclear envelope irregularities by tagging nuclear membrane proteins such as lamin B and emerin has resulted in a more objective definition of the shape of the nucleus. In this review we discuss in detail methodological issues as well as diagnostic and prognostic implications provided by decoration/staining of the nuclear envelope in both thyroid and breast cancer, thus demonstrating how much it matters "to be in the right shape" when dealing with pathological diagnosis of cancer.

Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages101-121
Number of pages21
Volume773
ISBN (Print)9781489980311
DOIs
Publication statusPublished - 2014

Publication series

NameAdvances in Experimental Medicine and Biology
Volume773
ISSN (Print)00652598

Fingerprint

Nuclear Envelope
Thyroid Neoplasms
Lamin Type B
Breast Neoplasms
Pathology
Staining and Labeling
Chromatin
Microscopic examination
Membrane Proteins
Coloring Agents
Tissue
Nuclear Proteins
In Situ Hybridization
Fluorescent Antibody Technique
Microscopy
DNA
Neoplasms
emerin

Keywords

  • 3D reconstruction
  • Breast cancer
  • Nuclei
  • Papillary carcinoma
  • Pleomorphism

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Bussolati, G., Maletta, F., Asioli, S., Annaratone, L., Sapino, A., & Marchiò, C. (2014). "To be or not to be in a good Shape": Diagnostic and clinical value of nuclear shape irregularities in thyroid and breast cancer. In Advances in Experimental Medicine and Biology (Vol. 773, pp. 101-121). (Advances in Experimental Medicine and Biology; Vol. 773). Springer New York LLC. https://doi.org/10.1007/978-1-4899-8032-8_5

"To be or not to be in a good Shape" : Diagnostic and clinical value of nuclear shape irregularities in thyroid and breast cancer. / Bussolati, Gianni; Maletta, Francesca; Asioli, Sofia; Annaratone, Laura; Sapino, Anna; Marchiò, Caterina.

Advances in Experimental Medicine and Biology. Vol. 773 Springer New York LLC, 2014. p. 101-121 (Advances in Experimental Medicine and Biology; Vol. 773).

Research output: Chapter in Book/Report/Conference proceedingChapter

Bussolati, G, Maletta, F, Asioli, S, Annaratone, L, Sapino, A & Marchiò, C 2014, "To be or not to be in a good Shape": Diagnostic and clinical value of nuclear shape irregularities in thyroid and breast cancer. in Advances in Experimental Medicine and Biology. vol. 773, Advances in Experimental Medicine and Biology, vol. 773, Springer New York LLC, pp. 101-121. https://doi.org/10.1007/978-1-4899-8032-8_5
Bussolati G, Maletta F, Asioli S, Annaratone L, Sapino A, Marchiò C. "To be or not to be in a good Shape": Diagnostic and clinical value of nuclear shape irregularities in thyroid and breast cancer. In Advances in Experimental Medicine and Biology. Vol. 773. Springer New York LLC. 2014. p. 101-121. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-1-4899-8032-8_5
Bussolati, Gianni ; Maletta, Francesca ; Asioli, Sofia ; Annaratone, Laura ; Sapino, Anna ; Marchiò, Caterina. / "To be or not to be in a good Shape" : Diagnostic and clinical value of nuclear shape irregularities in thyroid and breast cancer. Advances in Experimental Medicine and Biology. Vol. 773 Springer New York LLC, 2014. pp. 101-121 (Advances in Experimental Medicine and Biology).
@inbook{ac7093c6c5604171b51f66ec5225d5ba,
title = "{"}To be or not to be in a good Shape{"}: Diagnostic and clinical value of nuclear shape irregularities in thyroid and breast cancer",
abstract = "Variation in both nuclear shape and size ({"}pleomorphism{"}), coupled with changes in chromatin amount and distribution, remains the basic criteria for microscopy in a cytologic diagnosis of cancer. The biological determinants of nuclear shape irregularities are not clarified, so, rather than on the genesis of nuclear irregularities, we here focus our attention on a descriptive analysis of nuclear pleomorphism. We keep in mind that evaluation of nuclear shape as currently practiced in routine preparations is improper because it is indirectly based on the distribution of DNA as revealed by the affinity for basic dyes. Therefore, over the last years we have been using as criteria morphological features of nuclei of thyroid and breast carcinomas as determined by immunofluorescence, in situ hybridization, and 3D reconstruction. We have translated this approach to routine diagnostic pathology on tissue sections by employing immunoperoxidase staining for emerin. Direct detection of nuclear envelope irregularities by tagging nuclear membrane proteins such as lamin B and emerin has resulted in a more objective definition of the shape of the nucleus. In this review we discuss in detail methodological issues as well as diagnostic and prognostic implications provided by decoration/staining of the nuclear envelope in both thyroid and breast cancer, thus demonstrating how much it matters {"}to be in the right shape{"} when dealing with pathological diagnosis of cancer.",
keywords = "3D reconstruction, Breast cancer, Nuclei, Papillary carcinoma, Pleomorphism",
author = "Gianni Bussolati and Francesca Maletta and Sofia Asioli and Laura Annaratone and Anna Sapino and Caterina Marchi{\`o}",
year = "2014",
doi = "10.1007/978-1-4899-8032-8_5",
language = "English",
isbn = "9781489980311",
volume = "773",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "101--121",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - "To be or not to be in a good Shape"

T2 - Diagnostic and clinical value of nuclear shape irregularities in thyroid and breast cancer

AU - Bussolati, Gianni

AU - Maletta, Francesca

AU - Asioli, Sofia

AU - Annaratone, Laura

AU - Sapino, Anna

AU - Marchiò, Caterina

PY - 2014

Y1 - 2014

N2 - Variation in both nuclear shape and size ("pleomorphism"), coupled with changes in chromatin amount and distribution, remains the basic criteria for microscopy in a cytologic diagnosis of cancer. The biological determinants of nuclear shape irregularities are not clarified, so, rather than on the genesis of nuclear irregularities, we here focus our attention on a descriptive analysis of nuclear pleomorphism. We keep in mind that evaluation of nuclear shape as currently practiced in routine preparations is improper because it is indirectly based on the distribution of DNA as revealed by the affinity for basic dyes. Therefore, over the last years we have been using as criteria morphological features of nuclei of thyroid and breast carcinomas as determined by immunofluorescence, in situ hybridization, and 3D reconstruction. We have translated this approach to routine diagnostic pathology on tissue sections by employing immunoperoxidase staining for emerin. Direct detection of nuclear envelope irregularities by tagging nuclear membrane proteins such as lamin B and emerin has resulted in a more objective definition of the shape of the nucleus. In this review we discuss in detail methodological issues as well as diagnostic and prognostic implications provided by decoration/staining of the nuclear envelope in both thyroid and breast cancer, thus demonstrating how much it matters "to be in the right shape" when dealing with pathological diagnosis of cancer.

AB - Variation in both nuclear shape and size ("pleomorphism"), coupled with changes in chromatin amount and distribution, remains the basic criteria for microscopy in a cytologic diagnosis of cancer. The biological determinants of nuclear shape irregularities are not clarified, so, rather than on the genesis of nuclear irregularities, we here focus our attention on a descriptive analysis of nuclear pleomorphism. We keep in mind that evaluation of nuclear shape as currently practiced in routine preparations is improper because it is indirectly based on the distribution of DNA as revealed by the affinity for basic dyes. Therefore, over the last years we have been using as criteria morphological features of nuclei of thyroid and breast carcinomas as determined by immunofluorescence, in situ hybridization, and 3D reconstruction. We have translated this approach to routine diagnostic pathology on tissue sections by employing immunoperoxidase staining for emerin. Direct detection of nuclear envelope irregularities by tagging nuclear membrane proteins such as lamin B and emerin has resulted in a more objective definition of the shape of the nucleus. In this review we discuss in detail methodological issues as well as diagnostic and prognostic implications provided by decoration/staining of the nuclear envelope in both thyroid and breast cancer, thus demonstrating how much it matters "to be in the right shape" when dealing with pathological diagnosis of cancer.

KW - 3D reconstruction

KW - Breast cancer

KW - Nuclei

KW - Papillary carcinoma

KW - Pleomorphism

UR - http://www.scopus.com/inward/record.url?scp=84934434432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934434432&partnerID=8YFLogxK

U2 - 10.1007/978-1-4899-8032-8_5

DO - 10.1007/978-1-4899-8032-8_5

M3 - Chapter

C2 - 24563345

AN - SCOPUS:84934434432

SN - 9781489980311

VL - 773

T3 - Advances in Experimental Medicine and Biology

SP - 101

EP - 121

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -